A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth
Launched by CHILDREN'S NATIONAL RESEARCH INSTITUTE · Aug 18, 2021
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Cognitive/Behavioral capacity to benefit and understand Unstuck material as determined by teacher guided by probes related to pragmatic language that align with verbal demands of the curriculum.
- 2. Evidence of autism supported by at least one of the following:
- • Eligible and/or receiving school-based services or supports for autism
- • Prior clinical diagnosis of autism from a qualified health professional (as indicated by parent report)
- • Demonstrates characteristics of autism consistent with DSM-5, as judged by a clinical autism expert, based on all available information gathered through the screening, consenting, and testing process (including information gathered through the Social Communication Questionnaire via parent/teacher report, and SRS-2,)
- • 3. Capacity to benefit and understand unstuck material as determined by teacher
- Exclusion Criteria:
- • 1. Students must have a level of proficiency in English to complete questionnaires and study procedures in English. Parents must have a level of proficiency in English or Spanish to complete questionnaires and study procedures in English or Spanish.
- • 2. Student is not able to participate in UOT:HS due to their schedule or ability to benefit from curriculum material as determined by teacher.
About Children's National Research Institute
Children's National Research Institute is a leading pediatric research organization dedicated to advancing the understanding and treatment of childhood diseases. As an integral part of Children's National Hospital, the institute focuses on innovative clinical trials and translational research that aim to improve health outcomes for children. Through collaborations with academic institutions, industry partners, and community organizations, the institute fosters a multidisciplinary approach to research, emphasizing safety, ethical standards, and the integration of cutting-edge technology in pediatric care. With a commitment to addressing the unique health challenges faced by children, Children's National Research Institute strives to translate research findings into effective therapies and interventions that enhance the quality of life for young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rockville, Maryland, United States
Patients applied
Trial Officials
Lauren Kenworthy, PhD
Principal Investigator
Children's Research Institute, Children's National Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials